Notatum-Quentans Nasal 4X (BioResource Inc.)
Welcome to the PulseAid listing for the Notatum-Quentans Nasal 4X drug offered from BioResource Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | BioResource Inc. |
NON-PROPRIETARY NAME: | Penicillium Chrysogenum Var. Chrysogenum and Penicillium Glabrum |
SUBSTANCE NAME: | PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
Notatum-Quentans Nasal 4X HUMAN OTC DRUG Details:
Item Description | Notatum-Quentans Nasal 4X from BioResource Inc. |
LABELER NAME: | BioResource Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4; 4([hp_X]/10mL; [hp_X]/10mL) |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54256-046_6998060c-d0a7-49b7-917a-7456e6f2637c |
PRODUCT NDC: | 54256-046 |
APPLICATION NUMBER: | |
Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers: